Excretion of Ergometrine Maleate Injection into Breast Milk and Safety Evaluation of Breastfeeding

Author:

Chen miaomiao1,Song Tianmi1,Xu Jiacheng1,Chao Bingdi1,Wang Jie1,Luo Xin1,Qi Hongbo1

Affiliation:

1. The First Affiliated Hospital of Chongqing Medical University

Abstract

Abstract Background Ergometrine maleate injection as a first-line drug to prevent postpartum hemorrhage. To investigate the safety of ergometrine maleate injection and breastfeeding. Methods Pregnant women were recruited into this study according to the inclusion and exclusion criteria and their peripheral blood and breast milk were collected for the first time (some pregnant women have no milk at this time). After the delivery of the fetus, some parturients were further excluded according to the exclusion criteria. The recruited women were randomly divided into the control group and the treat group. The peripheral blood was collected in the control group at 2h and 12h after delivery, respectively, and the peripheral blood and breast milk were collected in the treat group at 2h, 4h, 6h and 12h after delivery, respectively. The concentrations of ergometrine maleate in maternal plasma and breast milk at different periods were detected by ultra-high-performance liquid chromatography coupled with mass spectrometry (UHPLC-MS), and prolactin levels at different time gradients after delivery were detected with chemiluminescence. Results Sixty-four women were finally recruited, with 32 in the treat group and 32 in the control group. The final concentration of ergometrine maleate injection reached the peak at 2h after administration and basically decreased to the pre-administration level at 12h after administration in both serum and breast milk. The RID was 4.5762% (2.5146%, 7.8638%) and 0.1842% (0.0000%, 1.1838%) at 6h and 12h after administration, respectively. Ergometrine maleate injection does not affect the PRL concentrations in peripheral blood at 2h and 12h. Conclusion The results suggest that breastfeeding at 12h after ergometrine maleate injection is relatively safe. In this study, ergometrine maleate injection was not found to inhibit the concentration of PRL in the peripheral blood, and no serious adverse reactions were found.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3